Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for ËÄÉ«AV's Generics Business Unit, discusses what makes ËÄÉ«AV unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2006
Process for the preparation of tamsulosin and intermediates thereof starting from chiral phenylethylamine and using catalytic hydrogenation as the key step
Read more
Scientific Article
/ Jan 01, 2006
Process for preparation of fluticasone analogs via esterification of a carbothioic acid
Read more
Scientific Article